Brookview Research, Inc.

Nashville, Tennessee 37203

0 studies enrolling now · 30 studies all time

What they study most

Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gestational Trophoblastic Tumor, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma, Vulvar Cancer

Studies at this site

• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer — Completed
• Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer — Completed
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix — Completed
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer — Completed
• Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer — Stopped early
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia — Completed
• Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
• Chemotherapy in Treating Patients With Sarcoma of the Uterus — Completed
• Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva — Stopped early
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer — Completed
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer — Completed
• Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer — Completed
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer — Completed
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer — Completed
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy — Completed
• Quality of Life in Survivors of Gynecologic Cancer — Completed
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer — Stopped early
• Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer — Stopped early
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix — Stopped early
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer — Stopped early
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early
• DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix — Completed
• Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Completed
• Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum — Status unconfirmed